YBGJ — Yubo International Biotech Cashflow Statement
0.000.00%
Last trade - 00:00
- $25.16m
- $25.16m
- $0.60m
2019 February 28th | 2020 February 29th | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.148 | -0.134 | -1.54 | -1.2 | -1.2 |
Depreciation | |||||
Non-Cash Items | — | — | 0.008 | — | — |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.116 | 0.112 | 0.492 | 0.577 | 0.266 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.032 | -0.022 | -1.02 | -0.601 | -0.739 |
Capital Expenditures | — | — | -0.565 | -0.04 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0 | — | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | 0 | -0.565 | -0.04 | 0 |
Financing Cash Flow Items | — | — | — | 0.669 | 0.746 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.034 | 0.019 | 0.127 | 0.669 | 0.746 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.002 | -0.003 | -1.36 | -0.009 | -0.012 |